Results 91 to 100 of about 59,082 (309)
Movement Disorders, EarlyView.Abstract Background The first International Parkinson and Movement Disorder Society Evidence‐Based Medicine (MDS‐EBM) review for essential tremor (ET) was published in 2019; since then, the modified Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology was adopted by MDS, and new evidence exists.
Deepa Dash +12 more
wiley +1 more source
Quantitative Reduction of Saliva Production with Botulinum Toxin Type B Injection into the Salivary Glands [PDF]
, 2005 Melissa Turk-Gonzales, Ib R. Odderson
openalex +1 more source
Neurourology and Urodynamics, EarlyView.ABSTRACT Introduction Management of overactive bladder (OAB) has a stepwise approach in adults and children. This does not account for individual patient variations, which may explain suboptimal outcomes in many patients. Distinct OAB profiles, based on patient characteristics, symptoms, urodynamic findings and imaging have been discussed in Part 1 ...
Michel Wyndaele +9 more
wiley +1 more source
Neurourology and Urodynamics, EarlyView.ABSTRACT Aims To summarize current evidence on β3‐adrenoceptor agonists for managing neurogenic lower urinary tract dysfunction (NLUTD), focusing on their efficacy, safety, and clinical role in optimizing bladder storage and protecting upper tracts. Methods Evidence from randomized controlled trials, meta‐analyses, and observational studies in spinal ...
Sharon E. Fishberg, Rano Matta
wiley +1 more source
Cosmetic use of botulinum toxin type A in the elderly
Clinical Interventions in Aging, 2007 Christine M ChengDepartment of Clinical Pharmacy, University of California, San Francisco, CA, USAAbstract: Botulinum toxin type A injections are one of the most popular cosmetic procedures for diminishing the appearance of facial lines caused by ...
Christine M Cheng
doaj
From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction
ToxinsSince its regulatory approval over a half-century ago, botulinum toxin has evolved from one of the most potent neurotoxins known to becoming routinely adopted in clinical practice.
Lucas Rempel +5 more
doaj +1 more source
Neurourology and Urodynamics, EarlyView.ABSTRACT Aims To explore the boundary of clinical use of sacral nerve stimulation (SNS) in neurogenic lower urinary tract dysfunction (NLUTD), identifying barriers to approval and early‐impact research questions. Methods This review is derived from a proposal discussion at the International Consultation on Incontinence‐Research Society in Bristol in ...
Marcus J. Drake +6 more
wiley +1 more source
Efficacy and Safety of Intra-Articular Botulinum Toxin A Injection for Knee Osteoarthritis
, 2023 Yoyos Dias Ismiarto +1 more
openalex +1 more source
Botulinum Toxin and Its Contribution to the Treatment of Masseteric Hypertrophy
Česká Stomatologie a Praktické Zubní Lékařství, 2005 With discovery and use of botulinum toxin masseteric hypertrophy has become treatable in a minimal invasive way. The authors discuss the masseteric hypertrophy as such as well as they describe a technique of clinical application of botulinum toxin in its
R. Jurkovič, P. Macák
doaj
Botulinum toxin in management of back pain
Quality in SportIntroduction The botulinum toxin is a widely used therapeutic agent. It is used for aesthetic reasons in treatment of glabellar wrinkles. Therapeutic indications include cervical dystonia, hyperhidrosis or migrenes.
Blanka Łuczak +9 more
doaj +1 more source